• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Innovative Approaches to the Diagnosis and Treatment of Glaucoma

Article

New Orleans-There is always something new to learn in any medical specialty, and speakers at a Monday evening CME program at the New Orleans Marriott described innovative approaches to glaucoma diagnosis and treatment.

Robert N. Weinreb, MD, University of California, San Diego, program chair and moderator, led off the discussion of advances in glaucoma treatment, followed by a presentation on risk assessment given by Robert D. Fechtner, MD, New Jersey Medical School and University of Medicine and Dentistry of New Jersey, Newark.

David S. Friedman, MD, MPH, shared strategies for the crucial task of determining whether a patient is going blind from glaucoma and, if so, how to respond. Marlene R. Moster, MD, Thomas Jefferson Medical College and Wills Eye Hospital, Philadelphia, discussed ways of overcoming the hurdles of glaucoma management. George A. "Jack" Cioffi, Devers Eye Institute, Legacy Health System, Portland, OR, concluded the presentations with an evaluation of the role of glaucoma surgery.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Alcon Laboratories Inc.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.